Free Trial

Health Catalyst (HCAT) News Today

$6.77
-0.15 (-2.17%)
(As of 05/21/2024 ET)
Health Catalyst's (HCAT) "Buy" Rating Reaffirmed at Canaccord Genuity Group
Canaccord Genuity Group reissued a "buy" rating and set a $11.00 target price on shares of Health Catalyst in a research note on Tuesday.
Massachusetts Financial Services Co. MA Purchases 206,184 Shares of Health Catalyst, Inc. (NASDAQ:HCAT)
Massachusetts Financial Services Co. MA increased its holdings in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 437.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 253,368 shares of the company
Health Catalyst, Inc. (NASDAQ:HCAT) Short Interest Up 9.7% in April
Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) was the target of a significant growth in short interest in the month of April. As of April 30th, there was short interest totalling 1,930,000 shares, a growth of 9.7% from the April 15th total of 1,760,000 shares. Based on an average daily trading volume, of 657,600 shares, the short-interest ratio is presently 2.9 days.
Stifel Nicolaus Keeps Their Hold Rating on Health Catalyst (HCAT)
Health Catalyst (NASDAQ:HCAT) Price Target Cut to $13.00 by Analysts at Wells Fargo & Company
Wells Fargo & Company dropped their price target on Health Catalyst from $14.00 to $13.00 and set an "overweight" rating on the stock in a research report on Friday.
KeyBanc Keeps Their Hold Rating on Health Catalyst (HCAT)
Health Catalyst, Inc. (NASDAQ:HCAT) Receives Consensus Rating of "Moderate Buy" from Brokerages
Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the eleven brokerages that are currently covering the stock, Marketbeat reports. Four analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendat
Health Catalyst earnings: here's what Wall Street expects
New Recommendation (April 30, 2024)
Short Interest in Health Catalyst, Inc. (NASDAQ:HCAT) Expands By 15.8%
Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) was the recipient of a large increase in short interest in April. As of April 15th, there was short interest totalling 1,760,000 shares, an increase of 15.8% from the March 31st total of 1,520,000 shares. Based on an average daily trading volume, of 616,300 shares, the days-to-cover ratio is presently 2.9 days.
Valmark Advisers Inc. Invests $1.20 Million in Health Catalyst, Inc. (NASDAQ:HCAT)
Valmark Advisers Inc. acquired a new position in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 130,000 shares of the company's stock, valu
Health Catalyst, Inc. (NASDAQ:HCAT) Sees Large Decline in Short Interest
Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) saw a large decrease in short interest in March. As of March 31st, there was short interest totalling 1,520,000 shares, a decrease of 16.5% from the March 15th total of 1,820,000 shares. Based on an average daily trading volume, of 617,600 shares, the short-interest ratio is presently 2.5 days.
Health Catalyst, Inc. (NASDAQ:HCAT) Given Consensus Rating of "Moderate Buy" by Brokerages
Shares of Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) have been assigned an average rating of "Moderate Buy" from the eleven ratings firms that are currently covering the firm, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold rating and seven have assign
Impax Asset Management Group plc Buys 600,000 Shares of Health Catalyst, Inc. (NASDAQ:HCAT)
Impax Asset Management Group plc lifted its stake in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 52.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,754,475 shares of the company's stock after acquiri
Health Catalyst's (HCAT) Overweight Rating Reaffirmed at Cantor Fitzgerald
Cantor Fitzgerald restated an "overweight" rating and set a $16.00 target price on shares of Health Catalyst in a research report on Wednesday.
Health Catalyst, Inc. (NASDAQ:HCAT) Shares Bought by Nepsis Inc.
Nepsis Inc. lifted its position in shares of Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 20.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,091,932 shares of the company's stock after acqu
Health Catalyst, Inc. (NASDAQ:HCAT) Given Consensus Recommendation of "Moderate Buy" by Analysts
Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) has been given an average recommendation of "Moderate Buy" by the fourteen research firms that are presently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a hold rating and ten have issued a buy ratin
HCAT Dec 2024 10.000 put
HCAT Apr 2024 7.500 put
HCAT Apr 2024 10.000 call
HCAT Dec 2024 17.500 call
Jacobs Levy Equity Management Inc. Has $7.72 Million Position in Health Catalyst, Inc. (NASDAQ:HCAT)
Jacobs Levy Equity Management Inc. lowered its stake in shares of Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 26.2% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 762,650 shares of the company's stock after sellin
Health Catalyst (NASDAQ:HCAT) Stock Price Up 6.3%
Health Catalyst (NASDAQ:HCAT) Shares Up 6.3%
Health Catalyst (NASDAQ:HCAT) Receives "Overweight" Rating from Cantor Fitzgerald
Cantor Fitzgerald reissued an "overweight" rating and issued a $16.00 price objective on shares of Health Catalyst in a report on Tuesday.
Bares Capital Management Inc. Lowers Position in Health Catalyst, Inc. (NASDAQ:HCAT)
Bares Capital Management Inc. reduced its position in shares of Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 10.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 700,000 shares of the company's stock a
Get Health Catalyst News Delivered to You Automatically

Sign up to receive the latest news and ratings for HCAT and its competitors with MarketBeat's FREE daily newsletter.

Warren Buffett's "mystery stock" (Ad)

WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion.

This Wall Street millionaire just stepped forward with all the details, and how it could make some

HCAT Media Mentions By Week

HCAT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

HCAT
News Sentiment

0.58

0.44

Average
Medical
News Sentiment

HCAT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

HCAT Articles
This Week

7

3

HCAT Articles
Average Week

Get Health Catalyst News Delivered to You Automatically

Sign up to receive the latest news and ratings for HCAT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:HCAT) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners